Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2019 | Story Valentino Ndaba
Be Safe on road
Be safe on the roads: Prevention is better than a hospital ward or coffin.

Safety starts with you, non-compliance ends you. A traffic spike over the Easter holidays does not justify disobeying road rules. The university is counting on all students, both drivers and pedestrians, to continue prioritising safety on the roads.

Don’t be a statistic, take responsibility
The 2018 Preliminary Easter Road Safety Report issued by the Department of Transport, indicated that most accidents were caused by irresponsibility.  “In 2018, human factor contributed 89,5% to crashes as compared to the 74,3% in 2017. The number of jay-walking pedestrians killed on our roads also increased to 38% as compared to 25,2% in 2017,” said Minister of Transport, Blade Nzimande.

The university implores you to play a role in reducing these numbers in 2019.

On driving and cellphones
According to Arrive Alive, the use of communication devices while driving is prohibited. “No person shall drive a vehicle on a public road while holding a cellular or mobile telephone or any other communication device in one or both hands or with any other part of the body, unless such a device is affixed to the vehicle or is part of the fixture in the vehicle.”

Pedestrian duties
Pedestrians are encouraged to practice caution when using sidewalks and while crossing the road. When walking, face oncoming traffic and pay attention to traffic signs so as not to constitute a source of danger to yourself or to traffic.

Safe speed saves lives
A general speed limit of 60 kilometres per hour shall apply to all public roads within urban areas, 100 kilometres per hour on public roads, and 120 kilometres per hour on freeways. Abide by these speed limits, unless stated otherwise by traffic signs.

More tips on drunken driving, wearing seat belts, and other aspects of road safety are easily available on the Arrive Alive website.

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept